+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Liquid Biopsy Market 2020-2024 - Product Image

Global Liquid Biopsy Market 2020-2024

  • ID: 5178346
  • Report
  • September 2020
  • Region: Global
  • 120 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • MORE
Global Liquid Biopsy Market 2020-2024

The liquid biopsy market is poised to grow by $ 4.02 bn during 2020-2024, progressing at a CAGR of 38% during the forecast period. This report on liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer and increasing focus on early detection of cancer. In addition, increasing funding for liquid biopsy is anticipated to boost the growth of the market as well.

The liquid biopsy market analysis includes the technology segment and geographical landscapes.

The liquid biopsy market is segmented as below:

By Technology
  • CTC and ctDNA
  • Exosome and RNA
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the growing focus on personalized medicine for cancer care as one of the prime reasons driving the liquid biopsy market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The liquid biopsy market covers the following areas:
  • Liquid biopsy market sizing
  • Liquid biopsy market forecast
  • Liquid biopsy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include ANGLE Plc, Biocept Inc., Bio-Techne Corp., CIRCULOGENE, F. Hoffmann-La Roche Ltd., Guardant Health Inc., LungLife AI Inc., Myriad Genetics Inc., QIAGEN NV, and SAGA Diagnostics AB. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Technology
  • Market segments
  • Comparison by Technology
  • CTC and ctDNA - Market size and forecast 2019-2024
  • Exosome and RNA - Market size and forecast 2019-2024
  • Market opportunity by Technology
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor Landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • LungLife AI Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • SAGA Diagnostics AB
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Technology - Market share 2019-2024 (%)
22: Comparison by Technology
23: CTC and ctDNA - Market size and forecast 2019-2024 ($ million)
24: CTC and ctDNA - Year-over-year growth 2019-2024 (%)
25: Exosome and RNA - Market size and forecast 2019-2024 ($ million)
26: Exosome and RNA - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Technology
28: Customer Landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: North America - Market size and forecast 2019-2024 ($ million)
32: North America - Year-over-year growth 2019-2024 (%)
33: Europe - Market size and forecast 2019-2024 ($ million)
34: Europe - Year-over-year growth 2019-2024 (%)
35: Asia - Market size and forecast 2019-2024 ($ million)
36: Asia - Year-over-year growth 2019-2024 (%)
37: ROW - Market size and forecast 2019-2024 ($ million)
38: ROW - Year-over-year growth 2019-2024 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor Landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: ANGLE Plc - Overview
48: ANGLE Plc - Business segments
49: ANGLE Plc - Key offerings
50: ANGLE Plc - Key customers
51: ANGLE Plc - Segment focus
52: Biocept Inc. - Overview
53: Biocept Inc. - Business segments
54: Biocept Inc. - Key offerings
55: Biocept Inc. - Key customers
56: Biocept Inc. - Segment focus
57: Bio-Techne Corp. - Overview
58: Bio-Techne Corp. - Business segments
59: Bio-Techne Corp. - Key offerings
60: Bio-Techne Corp. - Key customers
61: Bio-Techne Corp. - Segment focus
62: CIRCULOGENE - Overview
63: CIRCULOGENE - Product and service
64: CIRCULOGENE - Key offerings
65: CIRCULOGENE - Key customers
66: CIRCULOGENE - Segment focus
67: F. Hoffmann-La Roche Ltd. - Overview
68: F. Hoffmann-La Roche Ltd. - Business segments
69: F. Hoffmann-La Roche Ltd. - Key offerings
70: F. Hoffmann-La Roche Ltd. - Key customers
71: F. Hoffmann-La Roche Ltd. - Segment focus
72: Guardant Health Inc. - Overview
73: Guardant Health Inc. - Business segments
74: Guardant Health Inc. - Key offerings
75: Guardant Health Inc. - Key customers
76: Guardant Health Inc. - Segment focus
77: LungLife AI Inc. - Overview
78: LungLife AI Inc. - Product and service
79: LungLife AI Inc. - Key offerings
80: LungLife AI Inc. - Key customers
81: LungLife AI Inc. - Segment focus
82: Myriad Genetics Inc. - Overview
83: Myriad Genetics Inc. - Business segments
84: Myriad Genetics Inc. - Key offerings
85: Myriad Genetics Inc. - Key customers
86: Myriad Genetics Inc. - Segment focus
87: QIAGEN NV - Overview
88: QIAGEN NV - Business segments
89: QIAGEN NV - Key offerings
90: QIAGEN NV - Key customers
91: QIAGEN NV - Segment focus
92: SAGA Diagnostics AB - Overview
93: SAGA Diagnostics AB - Product and service
94: SAGA Diagnostics AB - Key offerings
95: SAGA Diagnostics AB - Key customers
96: SAGA Diagnostics AB - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global liquid biopsy market: ANGLE Plc, Biocept Inc., Bio-Techne Corp., CIRCULOGENE, F. Hoffmann-La Roche Ltd., Guardant Health Inc., LungLife AI Inc., Myriad Genetics Inc., QIAGEN NV, and SAGA Diagnostics AB.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the growing focus on personalized medicine for cancer care."

According to the report, one of the major drivers for this market is the increasing funding for liquid biopsy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • LungLife AI Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • SAGA Diagnostics AB
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll